Senexon-S is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Rugby Laboratories. The primary component is Docusate Sodium; Sennosides.
Product ID | 0536-1247_60e8c404-4bd9-4183-aefe-880d49774eee |
NDC | 0536-1247 |
Product Type | Human Otc Drug |
Proprietary Name | Senexon-S |
Generic Name | Docusate Sodium 50mg And Sennosides 8.6mg |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2019-10-02 |
Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
Application Number | part334 |
Labeler Name | RUGBY LABORATORIES |
Substance Name | DOCUSATE SODIUM; SENNOSIDES |
Active Ingredient Strength | 50 mg/1; mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2019-10-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-10-02 |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-10-02 |
Ingredient | Strength |
---|---|
SENNOSIDES | 8.6 mg/1 |
SPL SET ID: | 2e758ff1-3083-4245-8f58-1c47b042bfdd |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0536-1247 | Senexon-S | Docusate Sodium 50mg and Sennosides 8.6mg |
0536-4086 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
0615-7773 | SENEXON-S | docusate sodium-sennosides tablet |
0615-8083 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
0615-8331 | Senexon-S | Docusate Sodium 50mg and Sennosides 8.6mg |
33261-749 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
52959-675 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
68788-9407 | SENEXON-S | DOCUSATE SODIUM -SENNOSIDES |
43063-958 | Docusate Sodium With Sennosides | Docusate Sodium 50mg and Sennosides 8.6mg |